Inactive Instrument
Bellicum Pharmaceuticals, Inc. Share Price OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 17.65L 15.83L 14.47L 13.21L 24.88L 17Cr 25.66L 1.74Cr 69.53L 8.85Cr 66.24L 64.82L 28Cr | P/E 2021 |
-1.77x | P/E 2022 | -0.89x |
|---|---|---|---|---|---|
| Enterprise Value | -2.01Cr -1.8Cr -1.65Cr -1.5Cr -2.83Cr -188.68Cr -2.92Cr -20Cr -7.91Cr -100.68Cr -7.53Cr -7.37Cr -317.83Cr | EV / Sales 2021 |
-5.43x | EV / Sales 2022 | -10.4x |
| Free-Float |
98.45% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 23/02/2024 |
Richard Fair
CEO | Chief Executive Officer | 57 | 31/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 8L | |
| -4.83% | +3.51% | +53.62% | +61.75% | 6.59TCr | |
| -1.34% | +2.98% | +24.79% | +100.18% | 5.65TCr | |
| +0.02% | +1.07% | +10.63% | +76.66% | 5.69TCr | |
| +5.09% | +9.89% | +22.45% | +107.48% | 4.65TCr | |
| +2.62% | +1.68% | +28.91% | +37.01% | 4.48TCr | |
| +8.24% | +0.51% | +213.26% | +792.66% | 4.16TCr | |
| -1.86% | +10.13% | +26.82% | +53.22% | 3.53TCr | |
| -2.97% | -9.84% | +88.86% | +76.17% | 3.33TCr | |
| -2.18% | +7.06% | +36.06% | -4.95% | 2.49TCr | |
| Average | -0.39% | +3.25% | +56.16% | +144.47% | 4.51TCr | |
| Weighted average by Cap. | +0.21% | +3.40% | +53.12% | +142.96% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 62L 55.61L 50.82L 46.39L 87.41L 58Cr 90.16L 6.13Cr 2.44Cr 31Cr 2.33Cr 2.28Cr 98Cr | 15L 13.45L 12.3L 11.22L 21.15L 14Cr 21.81L 1.48Cr 59.1L 7.52Cr 56.3L 55.1L 24Cr |
| Net income | -97.05L -87.04L -79.55L -72.62L -1.37Cr -91Cr -1.41Cr -9.59Cr -3.82Cr -49Cr -3.64Cr -3.56Cr -153.67Cr | -2.5Cr -2.24Cr -2.05Cr -1.87Cr -3.52Cr -234.75Cr -3.63Cr -25Cr -9.84Cr -125.26Cr -9.37Cr -9.17Cr -395.43Cr |
| Net Debt | -4.62Cr -4.14Cr -3.78Cr -3.45Cr -6.51Cr -433.88Cr -6.71Cr -46Cr -18Cr -231.51Cr -17Cr -17Cr -730.85Cr | -2.18Cr -1.96Cr -1.79Cr -1.63Cr -3.08Cr -205.27Cr -3.18Cr -22Cr -8.6Cr -109.53Cr -8.2Cr -8.02Cr -345.77Cr |
Employees
13
